Magnetic Molecular Energizer research is being conducted under the auspices of an Institutional Review Board (IRB) as outlined in FDA regulations. This IRB consists of five or more physicians or health professionals who determine specific protocols and review the records of all cases treated.

Since extensive toxicity studies have already been conducted, MME research can focus on responses or benefits to any array of diagnosed conditions. When significant numbers of cases in a given category of treatment have been accumulated, the collective information will be submitted to the FDA for approval of the MME as an effective treatment for that particular condition so that it can become available to everyone.